TRACON Pharmaceuticals, Inc. Made Big Gain
Fri, Jun 14, 2024 at 07:17 PM
TRACON Pharmaceuticals, Inc. (TCON:NASDAQ) soared at $1.26, representing a gain of 29.9%. On Fri, Jun 14, 2024, TCON:NASDAQ touched a New 2-Week Intraday High of $1.48. The stock appeared on our News Catalysts scanner on Tue, Jun 11, 2024 at 10:35 AM in the 'BIOTECH' category. From Fri, May 31, 2024, the stock recorded 10.00% Up Days and 18.18% Green Days
The stock spiked on Wed, Mar 13, 2024 at $14.74 with a volume of 1M+.
About TRACON Pharmaceuticals, Inc. (TCON:NASDAQ)
TRACON Pharmaceuticals Inc is a clinical stage biopharmaceutical company. The Company is engaged in the development and commercialization of novel targeted therapeutics for cancer, age-related macular degeneration and fibrotic diseases.
Top 10 Gainers:
- La Rosa Holdings Corp. (LRHC:NASDAQ), 75.94%
- Unico American Corporation (UNAM:NASDAQ), 50%
- SRIVARU Holding Limited (SVMH:NASDAQ), 49.18%
- Republic First Bancorp, Inc. (FRBK:NASDAQ), 42.86%
- Nano Nuclear Energy Inc. (NNE:NASDAQ), 32.53%
- Cyclerion Therapeutics, Inc. (CYCN:NASDAQ), 32.47%
- Multi Ways Holdings Limited (MWG:NYSEMKT), 32%
- TRACON Pharmaceuticals, Inc. (TCON:NASDAQ), 29.9%
- Chijet Motor Company Inc. (CJET:NASDAQ), 27.59%
- MOGU Inc. (MOGU:NYSE), 24.49%